| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 59.614 | 51.632 | 7.076 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 60.202 | 52.265 | 8.095 | 63 | 107 | 135 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 47.052 | 41.544 | 6.343 | 254 | 82 | 62 | 40 | 59 | 0 | 0 |
| Gross Profit/Loss - EUR | 13.150 | 10.721 | 1.751 | -191 | 25 | 73 | -40 | -59 | 0 | 0 |
| Net Profit/Loss - EUR | 11.344 | 9.172 | 1.509 | -193 | 21 | 73 | -40 | -59 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Roneeda Cpap Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 17.118 | 25.481 | 26.363 | 10.625 | 10.012 | 9.895 | 9.636 | 9.662 | 9.632 | 9.578 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.457 | 8.378 | 5.264 | 5.170 | 5.071 | 4.974 | 4.864 | 4.879 | 4.864 | 4.837 |
| Cash | 13.661 | 17.103 | 21.099 | 5.455 | 4.941 | 4.921 | 4.772 | 4.783 | 4.768 | 4.741 |
| Shareholders Funds | 16.629 | 9.217 | 10.569 | 10.182 | 10.007 | 9.890 | 9.631 | 9.602 | 9.573 | 9.519 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 489 | 16.264 | 15.793 | 442 | 5 | 5 | 5 | 60 | 59 | 59 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Roneeda Cpap Srl